- Puneet Kumar ORCID:orcid.org/0000-0001-5378-19881,
- Priyesh Shukla1,
- Soni Kumari1,
- Ruhi Dixit1,
- Gopeshwar Narayan2,
- V. K. Dixit3 &
- …
- A. K. Khanna1
169Accesses
3Altmetric
Abstract
This study was designed to evaluate the correlation of expression profiles of MUC2, MUC4, and MUC5AC to the clinico-pathological parameters in gallbladder cancer. We recruited biopsies of a total of 60 subjects including 50 primary tumor biopsies from histopathologically proven gallbladder cancer and 10 cases of chronic cholecystitis as control. We have investigated the expression levels of MUC2, MUC4, and MUC5AC by semi-quantitative RT-PCR and immune-histochemistry in gallbladder cancer biopsies, and chronic cholecystitis as a control. Clinical correlation of the differential expression of MUC2, MUC4, and MUC5AC was determined using appropriate statistical methods. Our results demonstrated that MUC2 was significantly (p = 0.004) upregulated in 16%, MUC4 was significantly (p = 0.0004) upregulated in 24%, and MUC5AC was significantly (p = 0.003) upregulated in 32% samples at transcript levels in primary gallbladder cancer biopsies in comparison to the control. Similar to RT-PCR data, MUC2 was significantly (p = 0.001) upregulated in 30%, MUC4 was significantly (p = 0.047) upregulated in 48%, and MUC5AC was significantly (p = 0.002) upregulated in 52% samples at proteome levels in primary gallbladder cancer biopsies in comparison to the control. In conclusion, the MUC2, MUC4, and MUC5AC expression were found to be significantly upregulated in gallbladder cancer group than control. The overexpression of MUC2, MUC4, and MUC5AC suggested their association with gallbladder cancer.
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.


Similar content being viewed by others
References
Rakić M, Patrlj L, Kopljar M, Kliček R, Kolovrat M, Loncar B, Busic Z (2014) Gallbladder cancer Hepatobiliary Surg Nutr 3:221–226
Zhu AX, Hong TS, Hezel AF, Kooby DA (2010) Current management of gallbladder carcinoma. Oncologist 15:168–181
Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99–109
Yonezawa S, Higashi M, Yamada N, Yokoyama S, Kitamoto S, Kitajima S, Goto M (2011) Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application. Pathol Int 61:697–716
Albrecht H, Carraway KL (2011) 3rd MUC1 and MUC4: switching the emphasis from large to small. Cancer Biother Radiopharm 26:261–271
Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9:874–885
Kim SM, Oh SJ, Hur B (2012) Expression of MUC1 and MUC4 in gallbladder adenocarcinoma. Korean J Pathol 46:429–435
Vandenhaute B, Buisine MP, Debailleul V, Clément B, Moniaux N, Dieu MC, Degand P, Porchet N, Aubert JP (1997) Mucin gene expression in biliary epithelial cells. J Hepatol 27:1057–1066
Kumari S, Puneet PSB, Yadav SS, Kumar M, Khanna A et al (2016) Cyclin D1 andcyclin E2 are differentially expressed in gastric cancer. Med Oncol 33:40
Shukla HS, Tewari M (2007) Laparoscopy and gallbladder cancer. J Surg Oncol 96:91–92
Henson DE, Albores-Saavedra J, Corle D (1992) Carcinoma of the gallbladder. histologic types, stage of disease, grade, and survival rates. Cancer 70:1493–1497
Shukla VK, Pandey S, Pandey LK, Roy SK, Vaidya MP (1985) Primary hepatic pregnancy. Postgrad Med J 61:831–832
Ringel J, Löhr M (2003) The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer 2:9
Gautam SK, Kumar S, Dam V, Ghersi D, Jain M, Batra SK (2020) MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Semin Immunol 47:101391
Bhoge A, Khandeparkar SGS, Joshi AR, Gogate B, Kulkarni MM, Bhayekar P (2017) Immunohistochemical study of MUC1 and MUC5AC expression in gall bladder lesions. J Clin Diagn Res 11(7):EC12–EC16
Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS (2009) Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep 22:649–657
Barreto SG, Haga H, Shukla PJ (2009) Hormones and gallbladder cancer in women. Indian J Gastroenterol 28:126–130
Levin B (1999) Gallbladder carcinoma. Ann Oncol 4:129–130
Nervi F, Duarte I, Gomez G et al (1988) Frequency of gallbladder cancer in Chile. Int J Cancer 41:657–660
Diehl AK (1983) Gallstone size and the risk of gallbladder cancer. JAMA 250:2323–2326
Nakamura S, Sakaguchi S, Suzuki S, Muro H (1989) Aggressive surgery for carcinoma of gallbladder. Surgery 106:467–472
Xiong L, Yang Z, Yang L, Liu J (2012) Miao X (2012) Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. J Surg Oncol 105(1):97–103
Kaufman M, Mehrotra B, Limaye S, White S, Fuchs A, Lebowicz Y, Nissel-Horowitz S, Thomas A (2008) EGFR expression in gallbladder carcinoma in North America. Int J Med Sci 5:285–291
Lee HK, Cho MS, Kim TH (2012) Prognostic significance of muc4 expression in gallbladder carcinoma. World J Surg Oncol 10:224
Yamato T, Sasaki M, Watanabe Y, Nakanuma Y (1999) Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gallbladder carcinoma: an immunohistochemical and in situ hybridization study. J Pathol 188:30–37
Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK (2001) Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 7:4033–4040
Sasaki M, Nakanuma Y, Kim YS (1996) Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology 24:1074–1078
Boonla C, Wongkham S, Sheehan JK, Wongkham C, Bhudhisawasdi V, Tepsiri N, Pairojkul C (2003) Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer 98:1438–1443
Sasaki M, Yamato T, Nakanuma Y, Ho SB, Kim YS (1999) Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder. Pathol Int 49:38–44
Author information
Authors and Affiliations
Department of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varansi, 221005, India
Puneet Kumar, Priyesh Shukla, Soni Kumari, Ruhi Dixit & A. K. Khanna
Cancer Genetics Laboratory, Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi, 221005, India
Gopeshwar Narayan
Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varansi, 221005, India
V. K. Dixit
- Puneet Kumar
You can also search for this author inPubMed Google Scholar
- Priyesh Shukla
You can also search for this author inPubMed Google Scholar
- Soni Kumari
You can also search for this author inPubMed Google Scholar
- Ruhi Dixit
You can also search for this author inPubMed Google Scholar
- Gopeshwar Narayan
You can also search for this author inPubMed Google Scholar
- V. K. Dixit
You can also search for this author inPubMed Google Scholar
- A. K. Khanna
You can also search for this author inPubMed Google Scholar
Contributions
PK, PS, GN, VKD, AKK-Conceptualization.
PK, PS, SK, GN- Study design.
PS, SK-Project writing and management.
PK, PS, GN-Defining the study.
PS-Extensive literature work.
Experiments performing.
PS, SK-Practical work.
PS, SK-Operative work.
PS, SK-Data acquisition.
PK, PS, SK, GN-Data analysis.
PK, PS, SK, GN-Statistical inferences.
PK, PS, SK, RD, GN-Manuscript writing and editing.
PK, GN, VKD, AKK-Reviewing of the manuscript.
Corresponding author
Correspondence toPuneet Kumar.
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kumar, P., Shukla, P., Kumari, S.et al. Expression of Mucoproteins in Gallbladder Cancer.Indian J Surg84, 456–462 (2022). https://doi.org/10.1007/s12262-021-02989-7
Received:
Accepted:
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative